Goldman Sachs’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,000
Closed -$321K 6172
2022
Q3
$321K Buy
+23,000
New +$463K ﹤0.01% 5264

Other funds holding NEOG

Goldman Sachs's NEOG Position: Q2 2026 in Review

Goldman Sachs reduced its Neogen (NEOG) stake by 50% in Q2 2026, selling an estimated $10.3M and leaving 1,106,010 shares worth $9.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3234.

Goldman Sachs first reported a position in NEOG in Q2 2013 and has held it in 53 quarters since. The position peaked at $49.5M in Q2 2023. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Goldman Sachs held 1,106,010 shares of Neogen worth $9.94M as of Q2 2026.
  • Goldman Sachs sold 1,120,820 Neogen shares in Q2 2026, an estimated $10.3M.
  • Neogen made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3234 holding.
  • Goldman Sachs first reported a position in Neogen in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Neogen position peaked at $49.5M in Q2 2023.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.